Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Obtuse Language, Muddled Meanings Mark Scientific Fraud

November 17, 2015 4:36 pm | by Seth Augenstein, Digital Reporter | News | Comments

Obfuscated, muddled and willfully difficult jargon are a hallmark of scientific fraud, according to a new analysis of bunk science. Linguistic analysis of hundreds of retracted papers led to a model which could curb the growing phenomenon of retractions and ethical violations, according to the new study, published in the Journal of Language and Social Psychology. Read more...


Portable Brain Scanners, 3-D Models at SfN in Chicago

November 17, 2015 1:00 pm | by Drug Discovery & Development | Videos | Comments

In this one-minute video series, Drug Discovery & Development is highlighting the latest headlines and trends happening within the industry.


Clovis Oncology Shares Plunge over Poor Lung Cancer Response Rates

November 17, 2015 11:16 am | by Ryan Bushey, Associate Editor | News | Comments

The company’s stock plummeted 72 percent on Monday.


AbbVie: Virologic Response Rates in Hepatitis C Phase 2 Studies

November 17, 2015 10:57 am | News | Comments

​AbbVie, a global biopharmaceutical company, today announced data from the SURVEYOR studies of its investigational HCV regimen, ABT-493, an NS3/4A protease inhibitor, and ABT-530, an NS5A inhibitor, that show high rates of sustained virologic response at 12 weeks post-treatment (SVR12) in non-cirrhotic patients with chronic hepatitis C virus (HCV) infection. Read more...


Metabolic Profiles Distinguish Early-Stage Ovarian Cancer with Unprecedented Accuracy

November 17, 2015 10:27 am | by Georgia Institute of Technology | News | Comments

Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer. Read more...


RNA-Based Drugs Give More Control Over Gene Editing

November 17, 2015 10:04 am | by UC San Diego | News | Comments

CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes. Read more...


Johnson & Johnson Multiple Myeloma Drug Wins Accelerated OK

November 17, 2015 9:59 am | by Linda Johnson, AP Business Writer | News | Comments

A Johnson & Johnson drug won Food and Drug Administration approval Monday for treating the incurable blood cancer multiple myeloma in patients who've failed prior therapies and have few options left. Read more...

Studies Show China Continues to Lag in Effective Tobacco Control

November 17, 2015 8:15 am | by University of Waterloo | News | Comments

China is the world’s largest producer and consumer of tobacco, with more than 300 million smokers. Read more...


Duchenne Muscular Dystrophy is a Stem Cell Disease

November 17, 2015 8:00 am | by Ottawa Hospital Research Institute | News | Comments

Muscle stem cells are responsible for muscle repair after normal injuries and exercise. Read more...


Mouth Cancer Now Tenth Most Common Cancer in Men

November 17, 2015 7:45 am | by Cancer Research UK | News | Comments

It is the fifteenth most common cancer in women. Read more...


New Analyses Further Support Efficacy, Safety Profile for Boehringer's OFEV in IPF

November 17, 2015 7:30 am | News | Comments

Treatment with OFEV in the real-world clinical setting showed a safety profile consistent with that observed in clinical trials supporting its approval by the FDA. Read more...


Big Data Driving Earlier Cancer Diagnosis in England

November 17, 2015 7:15 am | by Public Health England | News | Comments

Rates of survival for cancer patients diagnosed as an emergency are much lower than through other routes. Read more...


Simple Urine Test Could Diagnose HCV

November 17, 2015 7:00 am | by Ryan Bushey, Associate Editor | News | Comments

This method could significantly reduce the time and cost it takes to accurately diagnose the disease. Read more...


FDA Approves AstraZeneca's Metastatic EGFR Treatment

November 16, 2015 12:52 pm | News | Comments

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Tagrisso (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy. Read more...


10 Percent of Diabetes Cases Among Adults Aged 50+ are Undiagnosed

November 16, 2015 11:50 am | by Trinity College Dublin | News | Comments

New research shows that 10 percent of adults aged 50 and over in Ireland, the equivalent to 120,000 older adults, have type 2 diabetes, rising to 16 percent in those aged 80 and over. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.